Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
26.32 USD | +1.25% | -13.01% | +137.57% |
May. 21 | Leerink Partners Starts Q32 Bio With Outperform Rating | MT |
May. 09 | Q32 Bio Inc. Provides Corporate Update | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+137.57% | 310M | |
+9.88% | 118B | |
+10.24% | 106B | |
-11.33% | 23.4B | |
-1.69% | 22.1B | |
-10.23% | 18.34B | |
-41.92% | 16.59B | |
-15.68% | 15.97B | |
+6.83% | 14.03B | |
+17.92% | 11.67B |
- Stock Market
- Equities
- QTTB Stock
- News Q32 Bio Inc.
- Chardan Lowers Price Target on Homology Medicines to $8 From $10, Keeps Buy Rating